Abstract: The present invention discloses methods and a kit for treating a respiratory syncytial virus infection. The method comprises providing an infection modulator, and administering a therapeutically effective amount of the infection modulator, wherein the respiratory syncytial virus infection is suppressed or precluded. The kit for suppressing a respiratory syncytial virus infection comprises an infection modulator, an applicator, and a set of instructions.
Type:
Grant
Filed:
March 14, 2003
Date of Patent:
November 7, 2006
Assignee:
Vanderbilt University
Inventors:
Ray Stokes Peebles, Jr., Koichi Hashimoto, Barney S. Graham
Abstract: The present invention relates to the delivery of compounds for the treatment of anxiety disorders and symptoms of such disorders through an inhalation route. Specifically, it relates to aerosols containing diazepam that are used in inhalation therapy. In a method aspect of the present invention, diazepam is administered to a patient through an inhalation route. The method comprises: a) heating a thin layer of diazepam on a solid support to form a vapor; and, b) passing air through the heated vapor to produce aerosol particles having less than 5% drug degradation products. In a kit aspect of the present invention, a kit for delivering diazepam through an inhalation route is provided which comprises: a) a thin coating of a diazepam composition; and, b) a device for dispending said thin coating as a condensation aerosol.
Type:
Grant
Filed:
March 3, 2004
Date of Patent:
August 8, 2006
Assignee:
Alexza Pharmaceuticals, Inc.
Inventors:
Joshua D. Rabinowitz, Alejandro C. Zaffaroni
Abstract: A pressurized aerosol and concentrate are described for treating moderate to severe foot and/or shoe odors. The aerosol contains micronized zinc oxide, a propellant and a solvent. Optionally, the aerosol may also contain a fragrance, a thickening agent and/or a base.
Type:
Grant
Filed:
September 29, 2000
Date of Patent:
July 18, 2006
Assignee:
Schering-Plough Healthcare Products Inc.
Abstract: A phenolic fraction of fruit obtained from the Rosaceae family and also to the process for the specific extraction of this fraction. The phenolic fraction is rich in dihydrochalcones (phloridzin and phloretin) and may be used as a cosmetic, dietary, or nutraceutical preparation.
Type:
Grant
Filed:
March 22, 2002
Date of Patent:
May 9, 2006
Assignee:
Diana Ingredients S.A.
Inventors:
David Gaudout, Denis Megard, Claude Inisan, Christian Esteve, Frédéric Lejard
Abstract: Carbamazepine, in extended release form, is useful in the treatment of patients suffering from bipolar disorder. In order to minimize the time it takes to reach efficacy, carbamazepine, in extended release form, can be administered to the patient at an initial daily dose which is then increased in daily increments until clinical efficacy is achieved.
Abstract: Continuous processes for converting cycloalkenes into ozonides in which ozone is reacted with a cycloalkene to form an ozonide solution. A portion of the solution is recycled back to the reaction, and additional cycloalkene is provided.
Type:
Grant
Filed:
September 24, 2001
Date of Patent:
July 23, 2002
Assignee:
E. I. du Pont de Nemours & Comp.
Inventors:
Edward F. Moran, Jr., Chester Arthur Thayer, II